Literature DB >> 34818611

Multi-scale semi-supervised clustering of brain images: Deriving disease subtypes.

Junhao Wen1, Erdem Varol2, Aristeidis Sotiras3, Zhijian Yang4, Ganesh B Chand5, Guray Erus4, Haochang Shou6, Ahmed Abdulkadir4, Gyujoon Hwang4, Dominic B Dwyer7, Alessandro Pigoni8, Paola Dazzan9, Rene S Kahn10, Hugo G Schnack11, Marcus V Zanetti12, Eva Meisenzahl13, Geraldo F Busatto12, Benedicto Crespo-Facorro14, Romero-Garcia Rafael15, Christos Pantelis16, Stephen J Wood17, Chuanjun Zhuo18, Russell T Shinohara6, Yong Fan4, Ruben C Gur19, Raquel E Gur19, Theodore D Satterthwaite20, Nikolaos Koutsouleris7, Daniel H Wolf20, Christos Davatzikos21.   

Abstract

Disease heterogeneity is a significant obstacle to understanding pathological processes and delivering precision diagnostics and treatment. Clustering methods have gained popularity for stratifying patients into subpopulations (i.e., subtypes) of brain diseases using imaging data. However, unsupervised clustering approaches are often confounded by anatomical and functional variations not related to a disease or pathology of interest. Semi-supervised clustering techniques have been proposed to overcome this and, therefore, capture disease-specific patterns more effectively. An additional limitation of both unsupervised and semi-supervised conventional machine learning methods is that they typically model, learn and infer from data using a basis of feature sets pre-defined at a fixed anatomical or functional scale (e.g., atlas-based regions of interest). Herein we propose a novel method, "Multi-scAle heteroGeneity analysIs and Clustering" (MAGIC), to depict the multi-scale presentation of disease heterogeneity, which builds on a previously proposed semi-supervised clustering method, HYDRA. It derives multi-scale and clinically interpretable feature representations and exploits a double-cyclic optimization procedure to effectively drive identification of inter-scale-consistent disease subtypes. More importantly, to understand the conditions under which the clustering model can estimate true heterogeneity related to diseases, we conducted extensive and systematic semi-simulated experiments to evaluate the proposed method on a sizeable healthy control sample from the UK Biobank (N = 4403). We then applied MAGIC to imaging data from Alzheimer's disease (ADNI, N = 1728) and schizophrenia (PHENOM, N = 1166) patients to demonstrate its potential and challenges in dissecting the neuroanatomical heterogeneity of common brain diseases. Taken together, we aim to provide guidance regarding when such analyses can succeed or should be taken with caution. The code of the proposed method is publicly available at https://github.com/anbai106/MAGIC.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clustering; Heterogeneity; Multi-scale; Semi-simulated; Semi-supervised

Mesh:

Year:  2021        PMID: 34818611      PMCID: PMC8678373          DOI: 10.1016/j.media.2021.102304

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  86 in total

1.  Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images.

Authors:  Carlton Chu; Ai-Ling Hsu; Kun-Hsien Chou; Peter Bandettini; Chingpo Lin
Journal:  Neuroimage       Date:  2011-12-01       Impact factor: 6.556

2.  Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.

Authors:  Nikolaos Koutsouleris; Eva M Meisenzahl; Stefan Borgwardt; Anita Riecher-Rössler; Thomas Frodl; Joseph Kambeitz; Yanis Köhler; Peter Falkai; Hans-Jürgen Möller; Maximilian Reiser; Christos Davatzikos
Journal:  Brain       Date:  2015-05-01       Impact factor: 13.501

3.  Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.

Authors:  Tianhao Zhang; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Davatzikos
Journal:  Schizophr Bull       Date:  2014-09-26       Impact factor: 9.306

4.  Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy.

Authors:  C Davatzikos; A Genc; D Xu; S M Resnick
Journal:  Neuroimage       Date:  2001-12       Impact factor: 6.556

5.  Analytic estimation of statistical significance maps for support vector machine based multi-variate image analysis and classification.

Authors:  Bilwaj Gaonkar; Christos Davatzikos
Journal:  Neuroimage       Date:  2013-04-10       Impact factor: 6.556

6.  Patterns of atrophy differ among specific subtypes of mild cognitive impairment.

Authors:  Jennifer L Whitwell; Ronald C Petersen; Selamawit Negash; Stephen D Weigand; Kejal Kantarci; Robert J Ivnik; David S Knopman; Bradley F Boeve; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2007-08

7.  Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns.

Authors:  Jong-Yun Park; Han Kyu Na; Sungsoo Kim; Hyunwook Kim; Hee Jin Kim; Sang Won Seo; Duk L Na; Cheol E Han; Joon-Kyung Seong
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

Review 8.  Multi-scale brain networks.

Authors:  Richard F Betzel; Danielle S Bassett
Journal:  Neuroimage       Date:  2016-11-11       Impact factor: 6.556

9.  Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.

Authors:  Alexandra L Young; Razvan V Marinescu; Neil P Oxtoby; Martina Bocchetta; Keir Yong; Nicholas C Firth; David M Cash; David L Thomas; Katrina M Dick; Jorge Cardoso; John van Swieten; Barbara Borroni; Daniela Galimberti; Mario Masellis; Maria Carmela Tartaglia; James B Rowe; Caroline Graff; Fabrizio Tagliavini; Giovanni B Frisoni; Robert Laforce; Elizabeth Finger; Alexandre de Mendonça; Sandro Sorbi; Jason D Warren; Sebastian Crutch; Nick C Fox; Sebastien Ourselin; Jonathan M Schott; Jonathan D Rohrer; Daniel C Alexander
Journal:  Nat Commun       Date:  2018-10-15       Impact factor: 14.919

10.  Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns.

Authors:  M Habes; D Janowitz; G Erus; J B Toledo; S M Resnick; J Doshi; S Van der Auwera; K Wittfeld; K Hegenscheid; N Hosten; R Biffar; G Homuth; H Völzke; H J Grabe; W Hoffmann; C Davatzikos
Journal:  Transl Psychiatry       Date:  2016-04-05       Impact factor: 6.222

View more
  2 in total

1.  Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression.

Authors:  Junhao Wen; Cynthia H Y Fu; Duygu Tosun; Yogasudha Veturi; Zhijian Yang; Ahmed Abdulkadir; Elizabeth Mamourian; Dhivya Srinivasan; Ioanna Skampardoni; Ashish Singh; Hema Nawani; Jingxuan Bao; Guray Erus; Haochang Shou; Mohamad Habes; Jimit Doshi; Erdem Varol; R Scott Mackin; Aristeidis Sotiras; Yong Fan; Andrew J Saykin; Yvette I Sheline; Li Shen; Marylyn D Ritchie; David A Wolk; Marilyn Albert; Susan M Resnick; Christos Davatzikos
Journal:  JAMA Psychiatry       Date:  2022-05-01       Impact factor: 25.911

2.  Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort.

Authors:  Jonah F Byrne; Colm Healy; David Mongan; Subash Raj Susai; Stan Zammit; Melanie Fӧcking; Mary Cannon; David R Cotter
Journal:  Transl Psychiatry       Date:  2022-09-09       Impact factor: 7.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.